X4 Pharmaceuticals, Inc Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • X4 Pharmaceuticals, Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 201M shares, a 1.97% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 178M shares, a 180% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 63.5M shares, a 147% increase from 2021.
  • X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 25.7M shares, a 28.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 178M +114M +180% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 63.5M +37.8M +147% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 25.7M +5.67M +28.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 20.1M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.